AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+10.19%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$101M
AUM Growth
+$101M
(+3.9%)
Cap. Flow
-$4.04M
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
22.09%
Holding
226
New
42
Increased
62
Reduced
35
Closed
61
Top Buys
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$1.25M |
| 2 |
Arcutis Biotherapeutics
ARQT
|
$1.16M |
| 3 |
ADC Therapeutics
ADCT
|
$1.14M |
| 4 |
Novavax
NVAX
|
$1.08M |
| 5 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$1.07M |
Top Sells
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$12.8M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
$2.1M |
| 3 |
Invesco S&P 500 Pure Value ETF
RPV
|
$2.08M |
| 4 |
Sanofi
SNY
|
$1.72M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
$1.59M |
Sector Composition
| 1 | Healthcare | 56.8% |
| 2 | Real Estate | 15.08% |
| 3 | Financials | 8.32% |
| 4 | Energy | 6.75% |
| 5 | Industrials | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rithm Capital
RITM
$6.57B
| $4.02M | 3.97% |
491,699
+54,680
| +13% | +$447K |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.9M | 2.87% |
25,500
-4,938
| -16% | -$562K |
|
3
Mr. Cooper
COOP
$12.1B
| $2.28M | 2.25% |
56,790
+4,050
| +8% | +$163K |
|
4
GSK
GSK
$79.9B
| $2.14M | 2.12% |
61,000
-9,000
| -13% | -$316K |
|
5
Procept Biorobotics
PRCT
$2.23B
| $2.08M | 2.05% |
50,000
| – | – |
|
|
EFC
6
Ellington Financial
EFC
$1.36B
| $2.04M | 2.02% |
165,154
+36,275
| +28% | +$449K |
|
7
Galapagos
GLPG
$2.07B
| $1.89M | 1.86% |
42,500
+12,500
| +42% | +$555K |
|
8
PennyMac Financial
PFSI
$5.69B
| $1.76M | 1.74% |
31,123
| – | – |
|
|
TSVT
9
DELISTED
2seventy bio
TSVT
| $1.69M | 1.67% |
180,000
+113,000
| +169% | +$1.06M |
|
|
MFA
10
MFA Financial
MFA
$1.05B
| $1.56M | 1.54% |
158,230
+25,000
| +19% | +$246K |
|
|
NYMT
11
New York Mortgage Trust
NYMT
$652M
| $1.53M | 1.51% |
595,731
+233,392
| +64% | +$597K |
|
12
Aurinia Pharmaceuticals
AUPH
$1.58B
| $1.52M | 1.5% |
352,500
+193,000
| +121% | +$834K |
|
|
13
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $1.49M | 1.47% |
187,500
+134,500
| +254% | +$1.07M |
|
|
VRNA
14
Verona Pharma
VRNA
$9.16B
| $1.44M | 1.42% |
55,000
+15,000
| +38% | +$392K |
|
15
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.44M | 1.42% |
125,000
+55,000
| +79% | +$631K |
|
16
Bio-Rad Laboratories Class A
BIO
$8.06B
| $1.43M | 1.41% |
3,400
+1,700
| +100% | +$715K |
|
17
AirSculpt Technologies
AIRS
$403M
| $1.33M | 1.32% |
360,000
+253,000
| +236% | +$936K |
|
18
Intuitive Surgical
ISRG
$170B
| $1.33M | 1.31% |
5,000
| – | – |
|
19
Allient
ALNT
$769M
| $1.31M | 1.29% |
37,500
| – | – |
|
20
AeroVironment
AVAV
$12.1B
| $1.28M | 1.27% |
15,000
| – | – |
|
21
Elanco Animal Health
ELAN
$9.12B
| $1.25M | 1.24% |
102,500
+25,000
| +32% | +$306K |
|
|
22
Ultragenyx Pharmaceutical
RARE
$2.89B
| $1.25M | 1.24% |
+27,000
| New | +$1.25M |
|
23
Starwood Property Trust
STWD
$7.44B
| $1.19M | 1.18% |
65,000
| – | – |
|
24
Fulgent Genetics
FLGT
$679M
| $1.18M | 1.16% |
39,500
+9,000
| +30% | +$268K |
|
|
25
Arcutis Biotherapeutics
ARQT
$1.86B
| $1.16M | 1.15% |
+78,500
| New | +$1.16M |
|